Causes and predictors of death among Finnish patients with systemic sclerosis.

IF 2.2 4区 医学 Q3 RHEUMATOLOGY Scandinavian Journal of Rheumatology Pub Date : 2024-07-01 Epub Date: 2024-05-14 DOI:10.1080/03009742.2024.2335781
S Kortelainen, M Käyrä, T Rissanen, J Paltta, K Taimen, L Pirilä, J Huhtakangas
{"title":"Causes and predictors of death among Finnish patients with systemic sclerosis.","authors":"S Kortelainen, M Käyrä, T Rissanen, J Paltta, K Taimen, L Pirilä, J Huhtakangas","doi":"10.1080/03009742.2024.2335781","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to assess causes and predictors of death among Finnish patients with systemic sclerosis (SSc).</p><p><strong>Method: </strong>Medical records of patients registered with the ICD-10 code M34 from 1996 to 2018 in two university hospitals were reviewed retrospectively. Clinical data were collected until the end of 2020. Death certificates were obtained from Statistics Finland up to August 2021. Using death certificates and patient records, the cause of death for each patient was determined. The mean age at death, median time from SSc diagnosis, and factors predicting death were analysed.</p><p><strong>Results: </strong>Among 313 SSc patients, 91 deaths occurred between April 2000 and September 2020. Overall 5 and 10 year survival rates were 88.4% and 80.2%, respectively. SSc was the most common primary cause of death (n = 35) and interstitial lung disease (ILD) was the most common SSc-related cause of death (n = 13). Moreover, 52% of the patients with diffuse SSc and 33% of those with limited cutaneous SSc died as a result of SSc itself. Patients who died because of SSc were significantly younger [mean ± sd age 65.6 ± 12.7 years, 95% confidence interval (CI) 61.2-70.1] than those who died from other causes (74.2 ± 9.6 years, 95% CI 71.5-76.9) (p = 0.0006). ILD, pulmonary arterial hypertension, gastrointestinal involvement, male gender, and older age at disease onset predicted death.</p><p><strong>Conclusion: </strong>The disease itself was the major cause of death among Finnish SSc patients, in both diffuse and limited forms of SSc.</p>","PeriodicalId":21424,"journal":{"name":"Scandinavian Journal of Rheumatology","volume":" ","pages":"269-275"},"PeriodicalIF":2.2000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03009742.2024.2335781","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/14 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The aim of this study was to assess causes and predictors of death among Finnish patients with systemic sclerosis (SSc).

Method: Medical records of patients registered with the ICD-10 code M34 from 1996 to 2018 in two university hospitals were reviewed retrospectively. Clinical data were collected until the end of 2020. Death certificates were obtained from Statistics Finland up to August 2021. Using death certificates and patient records, the cause of death for each patient was determined. The mean age at death, median time from SSc diagnosis, and factors predicting death were analysed.

Results: Among 313 SSc patients, 91 deaths occurred between April 2000 and September 2020. Overall 5 and 10 year survival rates were 88.4% and 80.2%, respectively. SSc was the most common primary cause of death (n = 35) and interstitial lung disease (ILD) was the most common SSc-related cause of death (n = 13). Moreover, 52% of the patients with diffuse SSc and 33% of those with limited cutaneous SSc died as a result of SSc itself. Patients who died because of SSc were significantly younger [mean ± sd age 65.6 ± 12.7 years, 95% confidence interval (CI) 61.2-70.1] than those who died from other causes (74.2 ± 9.6 years, 95% CI 71.5-76.9) (p = 0.0006). ILD, pulmonary arterial hypertension, gastrointestinal involvement, male gender, and older age at disease onset predicted death.

Conclusion: The disease itself was the major cause of death among Finnish SSc patients, in both diffuse and limited forms of SSc.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
芬兰系统性硬化症患者的死亡原因和预测因素。
目的:本研究旨在评估芬兰系统性硬化症(SSc)患者的死亡原因和预测因素:本研究旨在评估芬兰系统性硬化症(SSc)患者的死亡原因和预测因素:方法:对两家大学医院 1996 年至 2018 年期间以 ICD-10 编码 M34 登记的患者病历进行回顾性审查。临床数据收集至 2020 年底。从芬兰统计局获得了截至 2021 年 8 月的死亡证明。通过死亡证明和患者记录,确定了每位患者的死因。分析了死亡时的平均年龄、确诊为 SSc 的中位时间以及预测死亡的因素:在313名SSc患者中,有91人在2000年4月至2020年9月期间死亡。总体5年和10年生存率分别为88.4%和80.2%。SSc是最常见的主要死因(35例),间质性肺病(ILD)是最常见的SSc相关死因(13例)。此外,52%的弥漫性SSc患者和33%的局限性皮肤SSc患者死于SSc本身。死于 SSc 的患者明显比死于其他原因的患者(74.2 ± 9.6 岁,95% 置信区间 (CI) 71.5-76.9)年轻[平均年龄(±sd)为 65.6 ± 12.7 岁,95% 置信区间 (CI) 61.2-70.1](P = 0.0006)。ILD、肺动脉高压、胃肠道受累、男性和较高的发病年龄预示着死亡:结论:无论是弥漫型还是局限型SSc,疾病本身都是导致芬兰SSc患者死亡的主要原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.70
自引率
4.80%
发文量
90
审稿时长
6-12 weeks
期刊介绍: Scandinavian Journal of Rheumatology is the official journal of the Scandinavian Society for Rheumatology, a non-profit organization following the statutes of the Scandinavian Society for Rheumatology/Scandinavian Research Foundation. The main objective of the Foundation is to support research and promote information and knowledge about rheumatology and related fields. The annual surplus by running the Journal is awarded to young, talented, researchers within the field of rheumatology.pasting The Scandinavian Journal of Rheumatology is an international scientific journal covering clinical and experimental aspects of rheumatic diseases. The journal provides essential reading for rheumatologists as well as general practitioners, orthopaedic surgeons, radiologists, pharmacologists, pathologists and other health professionals with an interest in patients with rheumatic diseases. The journal publishes original articles as well as reviews, editorials, letters and supplements within the various fields of clinical and experimental rheumatology, including; Epidemiology Aetiology and pathogenesis Treatment and prophylaxis Laboratory aspects including genetics, biochemistry, immunology, immunopathology, microbiology, histopathology, pathophysiology and pharmacology Radiological aspects including X-ray, ultrasonography, CT, MRI and other forms of imaging.
期刊最新文献
Global health in axial spondyloarthritis: thresholds for the Assessment of SpondyloArthritis international Society Health Index and the EuroQol score: analysis of the ASAS-PerSpA study. Incident rheumatoid arthritis in patients living in Turkey and in Denmark: a comparative clinical, genetic, and serological study. Mitophagy drives maldifferentiation of tissue-resident memory T cells in patients with rheumatoid arthritis. Pristimerin inhibits the progression of antibody-induced autoimmune arthritis. Risk factors for shoulder pain and stiffness in adults aged 44 and older: an 11-year longitudinal population-based study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1